C4 Therapeutics Correlations
CCCC Stock | USD 2.50 0.08 3.10% |
The current 90-days correlation between C4 Therapeutics and Foghorn Therapeutics is -0.07 (i.e., Good diversification). The correlation of C4 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
C4 Therapeutics Correlation With Market
Good diversification
The correlation between C4 Therapeutics and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving together with CCCC Stock
0.73 | MCRB | Seres Therapeutics | PairCorr |
0.72 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.68 | MEIP | MEI Pharma | PairCorr |
0.71 | MGTX | MeiraGTx Holdings PLC | PairCorr |
0.73 | DNTH | Dianthus Therapeutics | PairCorr |
0.72 | VERV | Verve Therapeutics | PairCorr |
0.62 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.68 | MNMD | Mind Medicine | PairCorr |
0.74 | MNPR | Monopar Therapeutics | PairCorr |
Moving against CCCC Stock
0.39 | MDCX | Medicus Pharma | PairCorr |
0.36 | MDWD | Mediwound Earnings Call This Week | PairCorr |
0.71 | MLEC | Moolec Science SA | PairCorr |
0.68 | VCEL | Vericel Corp Ord | PairCorr |
0.48 | MLYS | Mineralys Therapeutics, Earnings Call This Week | PairCorr |
0.35 | VCYT | Veracyte | PairCorr |
0.65 | MREO | Mereo BioPharma Group | PairCorr |
0.52 | DWTX | Dogwood Therapeutics, Symbol Change | PairCorr |
0.39 | MRSN | Mersana Therapeutics Earnings Call This Week | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CCCC Stock performing well and C4 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze C4 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
FHTX | 3.44 | 0.06 | 0.05 | 0.14 | 3.86 | 8.89 | 22.61 | |||
STTK | 5.21 | (0.28) | 0.00 | (0.21) | 0.00 | 8.79 | 50.96 | |||
GLUE | 3.17 | (0.07) | 0.01 | 0.08 | 4.09 | 7.27 | 20.90 | |||
KYMR | 2.51 | 0.55 | 0.18 | (1.68) | 1.83 | 4.11 | 49.28 | |||
NRIX | 2.75 | (0.11) | (0.01) | 0.05 | 2.99 | 6.62 | 21.72 | |||
PRLD | 4.14 | 0.09 | 0.02 | 0.17 | 5.08 | 8.75 | 23.75 | |||
LUNG | 4.59 | (1.38) | 0.00 | (0.21) | 0.00 | 8.11 | 58.25 |
C4 Therapeutics Corporate Management
Paige Mahaney | Chief Officer | Profile | |
Kelly Schick | Chief Officer | Profile | |
Isabel Chiu | Senior Development | Profile | |
Mr MBA | Chief Officer | Profile | |
Andrew Hirsch | Pres CEO | Profile | |
Leonard MD | Chief Officer | Profile |